# Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

> clinical trial · VERIFIED · 2026-07-30

Status: RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Multiple Myeloma

- Company: M.D. Anderson Cancer Center
- Sector: Multiple Myeloma
- Primary source: https://clinicaltrials.gov/study/NCT06207799

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.